Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis
Increased circulating plasma urate concentration is associated with an increased risk of coronary heart disease, but the extent of any causative effect of urate on risk of coronary heart disease is still unclear. In this study, we aimed to clarify any causal role of urate on coronary heart disease r...
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Elsevier
2016
|
| _version_ | 1826275798366027776 |
|---|---|
| author | White, J Sofat, R Hemani, G Shah, T Engmann, J Dale, C Shah, S Kruger, F Giambartolomei, C Swerdlow, D Palmer, T McLachlan, S Langenberg, C Zabaneh, D Lovering, R Cavadino, A Jefferis, B Finan, C Wong, A Amuzu, A Ong, K Gaunt, T Warren, H Davies, T Drenos, F Cooper, J Ebrahim, S Lawlor, D Talmud, P Humphries, S Power, C Hypponen, E Richards, M Hardy, R Kuh, D Wareham, N Ben-Shlomo, Y Day, I Whincup, P Morris, R Strachan, M Price, J Kumari, M Kivimaki, M Plagnol, V Whittaker, J Smith, G Dudbridge, F Casas, J Holmes, M Hingorani, A |
| author_facet | White, J Sofat, R Hemani, G Shah, T Engmann, J Dale, C Shah, S Kruger, F Giambartolomei, C Swerdlow, D Palmer, T McLachlan, S Langenberg, C Zabaneh, D Lovering, R Cavadino, A Jefferis, B Finan, C Wong, A Amuzu, A Ong, K Gaunt, T Warren, H Davies, T Drenos, F Cooper, J Ebrahim, S Lawlor, D Talmud, P Humphries, S Power, C Hypponen, E Richards, M Hardy, R Kuh, D Wareham, N Ben-Shlomo, Y Day, I Whincup, P Morris, R Strachan, M Price, J Kumari, M Kivimaki, M Plagnol, V Whittaker, J Smith, G Dudbridge, F Casas, J Holmes, M Hingorani, A |
| author_sort | White, J |
| collection | OXFORD |
| description | Increased circulating plasma urate concentration is associated with an increased risk of coronary heart disease, but the extent of any causative effect of urate on risk of coronary heart disease is still unclear. In this study, we aimed to clarify any causal role of urate on coronary heart disease risk using Mendelian randomisation analysis.We first did a fixed-effects meta-analysis of the observational association of plasma urate and risk of coronary heart disease. We then used a conventional Mendelian randomisation approach to investigate the causal relevance using a genetic instrument based on 31 urate-associated single nucleotide polymorphisms (SNPs). To account for potential pleiotropic associations of certain SNPs with risk factors other than urate, we additionally did both a multivariable Mendelian randomisation analysis, in which the genetic associations of SNPs with systolic and diastolic blood pressure, HDL cholesterol, and triglycerides were included as covariates, and an Egger Mendelian randomisation (MR-Egger) analysis to estimate a causal effect accounting for unmeasured pleiotropy.In the meta-analysis of 17 prospective observational studies (166 486 individuals; 9784 coronary heart disease events) a 1 SD higher urate concentration was associated with an odds ratio (OR) for coronary heart disease of 1·07 (95% CI 1·04-1·10). The corresponding OR estimates from the conventional, multivariable adjusted, and Egger Mendelian randomisation analysis (58 studies; 198 598 individuals; 65 877 events) were 1·18 (95% CI 1·08-1·29), 1·10 (1·00-1·22), and 1·05 (0·92-1·20), respectively, per 1 SD increment in plasma urate.Conventional and multivariate Mendelian randomisation analysis implicates a causal role for urate in the development of coronary heart disease, but these estimates might be inflated by hidden pleiotropy. Egger Mendelian randomisation analysis, which accounts for pleiotropy but has less statistical power, suggests there might be no causal effect. These results might help investigators to determine the priority of trials of urate lowering for the prevention of coronary heart disease compared with other potential interventions.UK National Institute for Health Research, British Heart Foundation, and UK Medical Research Council. |
| first_indexed | 2024-03-06T23:04:16Z |
| format | Journal article |
| id | oxford-uuid:63401509-fd0f-4dd4-adbd-a15ed613b813 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:04:16Z |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:63401509-fd0f-4dd4-adbd-a15ed613b8132022-03-26T18:11:45ZPlasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:63401509-fd0f-4dd4-adbd-a15ed613b813EnglishSymplectic Elements at OxfordElsevier2016White, JSofat, RHemani, GShah, TEngmann, JDale, CShah, SKruger, FGiambartolomei, CSwerdlow, DPalmer, TMcLachlan, SLangenberg, CZabaneh, DLovering, RCavadino, AJefferis, BFinan, CWong, AAmuzu, AOng, KGaunt, TWarren, HDavies, TDrenos, FCooper, JEbrahim, SLawlor, DTalmud, PHumphries, SPower, CHypponen, ERichards, MHardy, RKuh, DWareham, NBen-Shlomo, YDay, IWhincup, PMorris, RStrachan, MPrice, JKumari, MKivimaki, MPlagnol, VWhittaker, JSmith, GDudbridge, FCasas, JHolmes, MHingorani, AIncreased circulating plasma urate concentration is associated with an increased risk of coronary heart disease, but the extent of any causative effect of urate on risk of coronary heart disease is still unclear. In this study, we aimed to clarify any causal role of urate on coronary heart disease risk using Mendelian randomisation analysis.We first did a fixed-effects meta-analysis of the observational association of plasma urate and risk of coronary heart disease. We then used a conventional Mendelian randomisation approach to investigate the causal relevance using a genetic instrument based on 31 urate-associated single nucleotide polymorphisms (SNPs). To account for potential pleiotropic associations of certain SNPs with risk factors other than urate, we additionally did both a multivariable Mendelian randomisation analysis, in which the genetic associations of SNPs with systolic and diastolic blood pressure, HDL cholesterol, and triglycerides were included as covariates, and an Egger Mendelian randomisation (MR-Egger) analysis to estimate a causal effect accounting for unmeasured pleiotropy.In the meta-analysis of 17 prospective observational studies (166 486 individuals; 9784 coronary heart disease events) a 1 SD higher urate concentration was associated with an odds ratio (OR) for coronary heart disease of 1·07 (95% CI 1·04-1·10). The corresponding OR estimates from the conventional, multivariable adjusted, and Egger Mendelian randomisation analysis (58 studies; 198 598 individuals; 65 877 events) were 1·18 (95% CI 1·08-1·29), 1·10 (1·00-1·22), and 1·05 (0·92-1·20), respectively, per 1 SD increment in plasma urate.Conventional and multivariate Mendelian randomisation analysis implicates a causal role for urate in the development of coronary heart disease, but these estimates might be inflated by hidden pleiotropy. Egger Mendelian randomisation analysis, which accounts for pleiotropy but has less statistical power, suggests there might be no causal effect. These results might help investigators to determine the priority of trials of urate lowering for the prevention of coronary heart disease compared with other potential interventions.UK National Institute for Health Research, British Heart Foundation, and UK Medical Research Council. |
| spellingShingle | White, J Sofat, R Hemani, G Shah, T Engmann, J Dale, C Shah, S Kruger, F Giambartolomei, C Swerdlow, D Palmer, T McLachlan, S Langenberg, C Zabaneh, D Lovering, R Cavadino, A Jefferis, B Finan, C Wong, A Amuzu, A Ong, K Gaunt, T Warren, H Davies, T Drenos, F Cooper, J Ebrahim, S Lawlor, D Talmud, P Humphries, S Power, C Hypponen, E Richards, M Hardy, R Kuh, D Wareham, N Ben-Shlomo, Y Day, I Whincup, P Morris, R Strachan, M Price, J Kumari, M Kivimaki, M Plagnol, V Whittaker, J Smith, G Dudbridge, F Casas, J Holmes, M Hingorani, A Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| title | Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| title_full | Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| title_fullStr | Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| title_full_unstemmed | Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| title_short | Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis |
| title_sort | plasma urate concentration and risk of coronary heart disease a mendelian randomisation analysis |
| work_keys_str_mv | AT whitej plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT sofatr plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT hemanig plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT shaht plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT engmannj plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT dalec plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT shahs plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT krugerf plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT giambartolomeic plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT swerdlowd plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT palmert plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT mclachlans plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT langenbergc plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT zabanehd plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT loveringr plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT cavadinoa plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT jefferisb plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT financ plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT wonga plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT amuzua plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT ongk plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT gauntt plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT warrenh plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT daviest plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT drenosf plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT cooperj plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT ebrahims plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT lawlord plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT talmudp plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT humphriess plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT powerc plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT hypponene plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT richardsm plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT hardyr plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT kuhd plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT warehamn plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT benshlomoy plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT dayi plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT whincupp plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT morrisr plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT strachanm plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT pricej plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT kumarim plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT kivimakim plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT plagnolv plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT whittakerj plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT smithg plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT dudbridgef plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT casasj plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT holmesm plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis AT hingorania plasmaurateconcentrationandriskofcoronaryheartdiseaseamendelianrandomisationanalysis |